Pixium Vision's 2020 financial calendar

Paris, France. December 11, 2019 – 06.00 PM CET– Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces its 2020 financial calendar*:

• 12^th February, 2020 – Full year 2019 financial results
• 16^th April, 2020 – Cash position of March 31^st, 2020
• 28^th May, 2020 – Annual General Shareholders' Meeting
• 23^rd July, 2020 – Half year 2020 financial results
• 22^nd October, 2020 – Cash position of September 30^th, 2020
   
   
   

• This financial calendar is for indicative purposes only. Pixium Vision may change the above dates if deemed necessary.

Contacts

Pixium Vision is creating a world of bionic vision for those who have lost their sight, enabling them to regain visual perception and greater autonomy. Pixium Vision's bionic vision systems are associated with a surgical intervention and a rehabilitation period. Prima System sub-retinal miniature photovoltaic wireless implant is in clinical testing for patients who have lost their sight due to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (dry AMD). Pixium Vision collaborates closely with academic and research partners, including some of the most prestigious vision research institutions in the world, such as: Stanford University in California, Institut de la Vision in Paris, Moorfields Eye Hospital in London, Institute of Ocular Microsurgery (IMO) in Barcelona, University hospital in Bonn, and UPMC in Pittsburgh, PA. The company is EN ISO 13485 certified and qualifies as “Entreprise Innovante” by Bpifrance.

For more information :  http://www.pixium-vision.com/fr

Follow us on @PixiumVision;  www.facebook.com/pixiumvision

              www.linkedin.com/company/pixium-vision 

Attachment

• Financial Calendar 2020